Eterna Therapeutics Inc. (ERNA)
undefined
undefined%
At close: undefined
0.33
-4.35%
Pre-market Jan 07, 2025, 06:32 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue 68.00K n/a n/a n/a 19.81M 23.34M 21.27M 22.31M 24.52M
Cost of Revenue 236.00K 497.00K 459.00K 98.00K 7.84M 8.38M 7.09M 8.13M 13.06M
Gross Profit -168.00K -497.00K -459.00K -98.00K 11.96M 14.95M 14.19M 14.18M 11.46M
Operating Income -21.14M -33.22M 68.34M -7.25M -1.21M 464.00K -1.40M -2.28M -6.60M
Interest Income 138.00K n/a n/a n/a n/a n/a n/a n/a 3.00K
Pretax Income -21.67M -24.53M -122.30M -7.29M -2.02M -323.00K -1.01M -2.88M -7.21M
Net Income -21.67M -24.58M -122.31M 11.91M -2.05M -259.00K -1.08M -2.92M -7.23M
Selling & General & Admin 14.59M 16.84M 14.72M 3.30M 13.15M 14.41M 15.45M 16.46M 18.06M
Research & Development 5.92M 10.39M 12.71M 3.95M 26.00K 72.00K 139.00K n/a n/a
Other Expenses 461.00K -1.17M 899.00K n/a n/a n/a n/a n/a n/a
Operating Expenses 20.97M 27.23M 27.43M 7.25M 13.18M 14.49M 15.59M 16.46M 18.06M
Interest Expense 614.00K 30.00K 74.00K 43.00K 249.00K 389.00K 498.00K 576.00K 484.00K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 21.20M 27.23M 27.43M 7.25M 21.02M 22.87M 22.68M 24.59M 31.12M
Income Tax -3.00K 45.00K 5.00K -19.20M 27.00K -64.00K 66.00K 38.00K 12.00K
Shares Outstanding (Basic) 5.31M 3.05M 2.17M 439.70K 71.88K 67.20K 61.05K 47.58K 45.95K
Shares Outstanding (Diluted) 5.31M 3.05M 2.17M 439.70K 71.88K 67.20K 61.05K 47.58K 45.95K
EPS (Basic) -4.08 -8.06 -56.49 27.08 -28.48 -3.85 -17.64 -61.44 -157.26
EPS (Diluted) -4.08 -8.06 -56.49 27.08 -28.48 -3.85 -17.64 -61.44 -157.26
EBITDA -19.93M -33.22M -121.95M -7.15M 1.96M 3.23M 915.00K 609.00K -3.63M
Depreciation & Amortization 1.12M 497.00K 459.00K 98.00K 3.17M 2.76M 2.32M 2.89M 3.10M